HF-FIA 4000

HF-FIA 3000

The Healfo SARS-CoV-2 Antigen Rapid Test is an in vitro immunochromatographic assay for qualitative detection of nucleocapsid protein antigen of the SARS-CoV-2 virus in nasopharyngeal (NP) swab specimens directly or after the swabs have been added to viral transport media from individuals who are suspected of COVID-19 by their healthcare provider.

The Healfo SARS-CoV-2 IgG/IgM Cassette Rapid Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in serum, plasma (EDTA, citrate) or venipuncture whole blood specimens from patients suspected of COVID-19 infection by a healthcare provider.

The Test Card is a lateral flow immunoassay intended for the qualitative detection of nucleocapsid protein antigen from 2019-nCoV in saliva specimens directly collected from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset.

The Healfo SARS-CoV-2 Neutralizing Antibody Rapid Test is a lateral flow immunoassay intended for the qualitative detection of neutralizing antibodies to SARS-CoV-2 in serum, plasma and whole blood. The Healfo SARS-CoV-2 Neutralizing Antibody Rapid Test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.